American Society of Gene & Cell Therapy (ASGCT) 17th Annual Meeting

简介（由申请人提供）：美国基因与细胞治疗学会（ASGCT）成立于1996年。ASGCT的使命是促进知识、意识和教育，从而发现和临床应用遗传和细胞疗法，以减轻人类疾病。我们的年会代表了协会的主要教育活动。这项R13提案要求为受训人员提供旅费补助金。大约四分之一的会员是正在培训的科学家，致力于开发临床应用的基因和细胞技术。年会通过一个独特的教育项目、众多的培训生旅行奖励以及通过同行评审的培训生卓越研究奖来表彰杰出的科学成就。在过去的十年中，ASGCT提供了620个旅行资助和68个研究奖励，其中180个旅行资助是在同一时期由美国国立卫生研究院提供的R13资助。旅行获奖者的教育机会包括杰出的全体会议演讲者，最先进的科学

DESCRIPTION (provided by applicant): American Society of Gene & Cell Therapy (ASGCT) was founded in 1996. ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. Our Annual Meeting represents the major educational initiative of the Society. This R13 proposal requests support for travel grants for trainees. Approximately 1/4 of our members are scientists in training working to develop clinically applicable gene and cell-based technologies. Trainee participation in the Annual Meeting is fostered by a distinctive educational program, numerous trainee travel awards, and recognition of outstanding scientific accomplishments through peer-reviewed trainee Excellence in Research Awards. Over the past decade, the ASGCT has offered 620 travel grants and 68 Research Awards, with 180 travel grants made possible by R13 grant awards from the NIH during that same time. Educational opportunities for travel awardees include exceptional plenary speakers, state-of-the-art scientific symposia, and educational sessions that review current thinking on a variety of topics. In addition to leading scientists and clinicians, the program includes ethicists and representatives from the FDA, OBA, and NIH so young scientists may gain insight into the compliance and ethical issues related to human gene therapy and cell therapy. Trainees are active presenters in oral abstract and poster presentations and the top trainee abstracts are recognized at the Presidential Symposium. The size of the ASGCT meeting (approximately 1,600 participants) is ideally suited to expose young scientists to leaders in the field, yet provide opportunities for trainees to present their work at the premier meeting in the field of gene and cell therapy. NIH support for the ASGCT Annual Meeting will allow continued educational and professional advancement of trainees in the field of cell and gene therapy in addition to the unique opportunity to network with leaders in the field.